Inventor
GAZIT AVIV
IL28 patents
⚠️ This page may combine multiple inventors who share the name “GAZIT AVIV”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YISSUM RES DEV CO
8 patentsUS5217999AJun 8, 1993
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
YISSUM RES DEV CO302 citations99
US5712395AJan 27, 1998
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
YISSUM RES DEV CO118 citations98
US5981569ANov 9, 1999
Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease
YISSUM RES DEV CO86 citations96
US5932580AAug 3, 1999
PDGF receptor kinase inhibitory compounds their preparation and compositions
YISSUM RES DEV CO95 citations96
US5196446AMar 23, 1993
Certain indole compounds which inhibit EGF receptor tyrosine kinase
YISSUM RES DEV CO101 citations96
USRE38761EJul 19, 2005
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
YISSUM RES DEV CO13 citations84
US6358954B1Mar 19, 2002
PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
YISSUM RES DEV CO16 citations80
US6673798B2Jan 6, 2004
PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
YISSUM RES DEV CO10 citations69
SUGEN INC
7 patentsUS5792771AAug 11, 1998
Quinazoline compounds and compositions thereof for the treatment of disease
SUGEN INC155 citations98
US5789427AAug 4, 1998
Methods and compositions for inhibiting cell proliferative disorders
SUGEN INC264 citations98
US5773476AJun 30, 1998
Methods and compositions for inhibiting cell proliferative disorders
SUGEN INC153 citations98
US5763441AJun 9, 1998
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
SUGEN INC111 citations97
US5990141ANov 23, 1999
Treatment of platelet derived growth factor related disorders such as cancers
SUGEN INC189 citations96
US5849742ADec 15, 1998
Compounds for the treament of disorders related to vasculogenesis and/or angiogenesis
SUGEN INC28 citations92
US7217737B2May 15, 2007
Method and compositions for inhibiting cell proliferative disorders
SUGEN INC3 citations62
MAX PLANCK GESELLSCHAFT
3 patentsUS5851999ADec 22, 1998
FLK-1 is a receptor for vascular endothelial growth factor
MAX PLANCK GESELLSCHAFT160 citations97
US6872699B2Mar 29, 2005
Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein
MAX PLANCK GESELLSCHAFT6 citations72
US7964399B2Jun 21, 2011
Cell line comprising vector encoding truncated FLK-1 receptor
MAX PLANCK GESELLSCHAFT1 citations51